Mannitol-Coated Hydroxypropyl Methylcellulose as a Directly Compressible Controlled Release Excipient for Moisture-Sensitive Drugs: A Stability Perspective

Background/Objectives: Hydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for controlled release applications. However, HPMC attracts moisture and poses issues with drug stability in formulations containing moisture-sensitive...

Full description

Saved in:
Bibliographic Details
Published inPharmaceuticals (Basel, Switzerland) Vol. 17; no. 9; p. 1167
Main Authors Kang, Christina Yong Xin, Chow, Keat Theng, Lui, Yuan Siang, Salome, Antoine, Boit, Baptiste, Lefevre, Philippe, Hiew, Tze Ning, Gokhale, Rajeev, Heng, Paul Wan Sia
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.09.2024
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background/Objectives: Hydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for controlled release applications. However, HPMC attracts moisture and poses issues with drug stability in formulations containing moisture-sensitive drugs. Methods: Herein, the moisture sorption behavior of excipients and drug stability using aspirin as the model drug in matrix tablets were evaluated, using HPMC and the newly developed mannitol-coated HPMC, under accelerated stability conditions (40 °C, 75% relative humidity) with open and closed dishes. Results: Tablets prepared with mannitol-coated HPMC showed a slower drug degradation rate compared to tablets prepared with directly compressible HPMC. Initial moisture content and hygroscopicity were stronger predictors of drug stability compared to water activity when comparing samples without similar moisture content. In the early stage (day 0 to 30), the aspirin degradation rate was similar in both open and closed conditions, as moisture content is the main degradation contributor. In the later stage (day 30 to 90), aspirin degradation was faster under closed conditions than under open conditions, likely due to autocatalytic effects caused by the volatile acidic by-product entrapped in the closed environment. Conclusions: The findings from this study reinforced the importance of judicious excipient selection based on the understanding of excipient–moisture interactions to maximize the chemical stability of moisture-sensitive drugs. Mannitol-coated HPMC is a promising addition to the formulator’s toolbox for the formulation of controlled release dosage forms by direct compression.
AbstractList Hydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for controlled release applications. However, HPMC attracts moisture and poses issues with drug stability in formulations containing moisture-sensitive drugs.BACKGROUND/OBJECTIVESHydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for controlled release applications. However, HPMC attracts moisture and poses issues with drug stability in formulations containing moisture-sensitive drugs.Herein, the moisture sorption behavior of excipients and drug stability using aspirin as the model drug in matrix tablets were evaluated, using HPMC and the newly developed mannitol-coated HPMC, under accelerated stability conditions (40 °C, 75% relative humidity) with open and closed dishes.METHODSHerein, the moisture sorption behavior of excipients and drug stability using aspirin as the model drug in matrix tablets were evaluated, using HPMC and the newly developed mannitol-coated HPMC, under accelerated stability conditions (40 °C, 75% relative humidity) with open and closed dishes.Tablets prepared with mannitol-coated HPMC showed a slower drug degradation rate compared to tablets prepared with directly compressible HPMC. Initial moisture content and hygroscopicity were stronger predictors of drug stability compared to water activity when comparing samples without similar moisture content. In the early stage (day 0 to 30), the aspirin degradation rate was similar in both open and closed conditions, as moisture content is the main degradation contributor. In the later stage (day 30 to 90), aspirin degradation was faster under closed conditions than under open conditions, likely due to autocatalytic effects caused by the volatile acidic by-product entrapped in the closed environment.RESULTSTablets prepared with mannitol-coated HPMC showed a slower drug degradation rate compared to tablets prepared with directly compressible HPMC. Initial moisture content and hygroscopicity were stronger predictors of drug stability compared to water activity when comparing samples without similar moisture content. In the early stage (day 0 to 30), the aspirin degradation rate was similar in both open and closed conditions, as moisture content is the main degradation contributor. In the later stage (day 30 to 90), aspirin degradation was faster under closed conditions than under open conditions, likely due to autocatalytic effects caused by the volatile acidic by-product entrapped in the closed environment.The findings from this study reinforced the importance of judicious excipient selection based on the understanding of excipient-moisture interactions to maximize the chemical stability of moisture-sensitive drugs. Mannitol-coated HPMC is a promising addition to the formulator's toolbox for the formulation of controlled release dosage forms by direct compression.CONCLUSIONSThe findings from this study reinforced the importance of judicious excipient selection based on the understanding of excipient-moisture interactions to maximize the chemical stability of moisture-sensitive drugs. Mannitol-coated HPMC is a promising addition to the formulator's toolbox for the formulation of controlled release dosage forms by direct compression.
Background/Objectives: Hydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for controlled release applications. However, HPMC attracts moisture and poses issues with drug stability in formulations containing moisture-sensitive drugs. Methods: Herein, the moisture sorption behavior of excipients and drug stability using aspirin as the model drug in matrix tablets were evaluated, using HPMC and the newly developed mannitol-coated HPMC, under accelerated stability conditions (40 °C, 75% relative humidity) with open and closed dishes. Results: Tablets prepared with mannitol-coated HPMC showed a slower drug degradation rate compared to tablets prepared with directly compressible HPMC. Initial moisture content and hygroscopicity were stronger predictors of drug stability compared to water activity when comparing samples without similar moisture content. In the early stage (day 0 to 30), the aspirin degradation rate was similar in both open and closed conditions, as moisture content is the main degradation contributor. In the later stage (day 30 to 90), aspirin degradation was faster under closed conditions than under open conditions, likely due to autocatalytic effects caused by the volatile acidic by-product entrapped in the closed environment. Conclusions: The findings from this study reinforced the importance of judicious excipient selection based on the understanding of excipient–moisture interactions to maximize the chemical stability of moisture-sensitive drugs. Mannitol-coated HPMC is a promising addition to the formulator’s toolbox for the formulation of controlled release dosage forms by direct compression.
Hydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for controlled release applications. However, HPMC attracts moisture and poses issues with drug stability in formulations containing moisture-sensitive drugs. Herein, the moisture sorption behavior of excipients and drug stability using aspirin as the model drug in matrix tablets were evaluated, using HPMC and the newly developed mannitol-coated HPMC, under accelerated stability conditions (40 °C, 75% relative humidity) with open and closed dishes. Tablets prepared with mannitol-coated HPMC showed a slower drug degradation rate compared to tablets prepared with directly compressible HPMC. Initial moisture content and hygroscopicity were stronger predictors of drug stability compared to water activity when comparing samples without similar moisture content. In the early stage (day 0 to 30), the aspirin degradation rate was similar in both open and closed conditions, as moisture content is the main degradation contributor. In the later stage (day 30 to 90), aspirin degradation was faster under closed conditions than under open conditions, likely due to autocatalytic effects caused by the volatile acidic by-product entrapped in the closed environment. The findings from this study reinforced the importance of judicious excipient selection based on the understanding of excipient-moisture interactions to maximize the chemical stability of moisture-sensitive drugs. Mannitol-coated HPMC is a promising addition to the formulator's toolbox for the formulation of controlled release dosage forms by direct compression.
Audience Academic
Author Hiew, Tze Ning
Kang, Christina Yong Xin
Heng, Paul Wan Sia
Salome, Antoine
Lui, Yuan Siang
Lefevre, Philippe
Gokhale, Rajeev
Chow, Keat Theng
Boit, Baptiste
AuthorAffiliation 2 GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore; paulwsheng@outlook.com
3 Roquette Frères, 1 Rue de la Haute Loge, 62136 Lestrem, France
4 Roquette America Inc., 2211 Innovation Drive, Geneva, IL 60134, USA
1 Roquette Asia Pacific Pte. Ltd., 11 Biopolis Way, Helios, #05-06, Singapore 138667, Singapore
AuthorAffiliation_xml – name: 2 GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore; paulwsheng@outlook.com
– name: 4 Roquette America Inc., 2211 Innovation Drive, Geneva, IL 60134, USA
– name: 1 Roquette Asia Pacific Pte. Ltd., 11 Biopolis Way, Helios, #05-06, Singapore 138667, Singapore
– name: 3 Roquette Frères, 1 Rue de la Haute Loge, 62136 Lestrem, France
Author_xml – sequence: 1
  givenname: Christina Yong Xin
  orcidid: 0000-0002-6398-6511
  surname: Kang
  fullname: Kang, Christina Yong Xin
– sequence: 2
  givenname: Keat Theng
  surname: Chow
  fullname: Chow, Keat Theng
– sequence: 3
  givenname: Yuan Siang
  surname: Lui
  fullname: Lui, Yuan Siang
– sequence: 4
  givenname: Antoine
  surname: Salome
  fullname: Salome, Antoine
– sequence: 5
  givenname: Baptiste
  surname: Boit
  fullname: Boit, Baptiste
– sequence: 6
  givenname: Philippe
  surname: Lefevre
  fullname: Lefevre, Philippe
– sequence: 7
  givenname: Tze Ning
  orcidid: 0000-0002-2313-7806
  surname: Hiew
  fullname: Hiew, Tze Ning
– sequence: 8
  givenname: Rajeev
  surname: Gokhale
  fullname: Gokhale, Rajeev
– sequence: 9
  givenname: Paul Wan Sia
  surname: Heng
  fullname: Heng, Paul Wan Sia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39338330$$D View this record in MEDLINE/PubMed
BookMark eNptkt9u0zAUhyM0xP7ADQ-AInGDkDrs2GkcblDVDTZpFYjBtXXsnLSe3DjYzrQ8Cy-Lu25snRZfJLa_80XH_h1me53rMMveUnLMWE0-9StakZrSafUiO6C84BNR8Grv0fd-dhjCFSFlRTl9le2zmjHBGDnI_i6g60x0djJ3ELHJz8bGu5ux964fbb7AuBqtRmsH6wLmEHLIT4xHHe2Yz9269xiCURbTpIveWZscP9EiJPr0RpveYBfz1vl84UyIg8fJJXbBRHON-YkfluFzPssvIyhjTRzzH-hDn_Rp-3X2sgUb8M3d-yj7_fX01_xscvH92_l8djHRJSdx0oBmValAaFAlLUoGU65YS5jgtVIVEawQ6RAIK1RRNfVUU12xEltBhAKghB1l51tv4-BK9t6swY_SgZG3C84vJfhotEUJoiV1Km_aVnFCdY3ItGq1KBTWUPDk-rJ19YNaY6NT8x7sjnR3pzMruXTXklLOSlbRZPhwZ_Duz4AhyrUJmxuADt0QJKM0XTYRlUjo-yfolRt8l87qlpqWdc35A7WE1IHpWpd-rDdSOROUVJunSNTxM1QaDa6NToFrTVrfKXj3uNP_Ld5nKwFkC2jvQvDYSm0iRLPJCRgrKZGb-MqH-KaSj09K7q3PwP8AZu7xsQ
CitedBy_id crossref_primary_10_1016_j_ijpharm_2024_124816
Cites_doi 10.1080/03639045.2016.1249374
10.1351/pac198557040603
10.1016/S0378-5173(98)00050-7
10.1002/jps.21033
10.1208/s12248-016-9934-x
10.1111/j.1365-2621.1991.tb07964.x
10.1016/j.powtec.2018.10.054
10.1080/10837450.2022.2152048
10.1002/jps.2600511112
10.1002/jps.22161
10.1039/tf9524800696
10.3109/03639048709105213
10.4103/2230-973X.96922
10.1007/978-3-319-20206-8_1
10.1016/0378-5173(90)90221-O
10.1007/s11095-009-9861-y
10.1023/A:1015877011807
10.3109/03639048809151962
10.1007/s11095-017-2252-x
10.1016/S0958-6946(01)00153-4
10.1016/j.powtec.2013.03.008
10.1016/j.ejpb.2016.02.010
10.1081/DDC-120024188
10.1080/17425247.2021.1873946
10.1016/j.ejps.2020.105502
10.1016/j.ijpharm.2019.05.073
10.1081/PDT-120003494
10.1080/10837450.2020.1832520
10.1016/j.ijpharm.2020.119343
10.1002/9781118373941
10.1002/jps.1090
10.1021/acs.molpharmaceut.0c00804
10.1208/s12249-013-0036-0
10.1016/j.jddst.2019.05.028
10.1016/j.ijpharm.2024.124298
10.1016/j.jpba.2019.01.016
10.1016/j.ijpharm.2016.07.052
10.1021/la402630s
10.1016/j.ijpharm.2015.10.068
10.1016/j.ijpharm.2018.05.026
10.1016/j.ijpharm.2020.119218
10.3109/10837450.2013.775154
10.1016/j.colsurfb.2014.09.058
10.1002/star.19910430304
10.1016/j.ijpharm.2017.01.010
10.1016/j.ijpharm.2004.12.013
10.1002/jps.3030470509
10.1002/jps.2600740709
10.1016/j.jconrel.2011.04.002
10.1021/acs.molpharmaceut.4c00031
10.1002/jps.2600770407
ContentType Journal Article
Copyright COPYRIGHT 2024 MDPI AG
2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 by the authors. 2024
Copyright_xml – notice: COPYRIGHT 2024 MDPI AG
– notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 by the authors. 2024
DBID AAYXX
CITATION
NPM
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/ph17091167
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
ProQuest Central Student
ProQuest Research Library
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Publicly Available Content Database
CrossRef


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1424-8247
ExternalDocumentID oai_doaj_org_article_a8f09c73dffb401c9ee3cbfc82be9a24
PMC11435371
A810777772
39338330
10_3390_ph17091167
Genre Journal Article
GeographicLocations France
Singapore
GeographicLocations_xml – name: France
– name: Singapore
GrantInformation_xml – fundername: Roquette
  grantid: N/A
– fundername: Roquette
GroupedDBID ---
2WC
53G
5VS
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACUHS
ADBBV
AEAQA
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EBD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RPM
TUS
NPM
PMFND
3V.
7XB
8FK
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c540t-dac375ba8cab51253a64b3f03849bb708328824032b27d96c1c735ef808baa103
IEDL.DBID BENPR
ISSN 1424-8247
IngestDate Wed Aug 27 01:15:41 EDT 2025
Thu Aug 21 18:31:14 EDT 2025
Fri Jul 11 05:04:54 EDT 2025
Mon Jun 30 16:02:40 EDT 2025
Tue Jun 17 22:03:52 EDT 2025
Tue Jun 10 21:02:08 EDT 2025
Mon Jul 21 05:40:19 EDT 2025
Tue Jul 01 04:13:55 EDT 2025
Thu Apr 24 23:01:58 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords hydroxypropyl methylcellulose
aspirin
co-processed
mannitol
stability
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-dac375ba8cab51253a64b3f03849bb708328824032b27d96c1c735ef808baa103
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Current address: Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, The University of Iowa, 180 South Grand Avenue, Iowa City, IA 52242, USA.
Current address: Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, East Java, Indonesia.
ORCID 0000-0002-6398-6511
0000-0002-2313-7806
OpenAccessLink https://www.proquest.com/docview/3110659944?pq-origsite=%requestingapplication%
PMID 39338330
PQID 3110659944
PQPubID 2032350
ParticipantIDs doaj_primary_oai_doaj_org_article_a8f09c73dffb401c9ee3cbfc82be9a24
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11435371
proquest_miscellaneous_3110910878
proquest_journals_3110659944
gale_infotracmisc_A810777772
gale_infotracacademiconefile_A810777772
pubmed_primary_39338330
crossref_citationtrail_10_3390_ph17091167
crossref_primary_10_3390_ph17091167
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-09-01
PublicationDateYYYYMMDD 2024-09-01
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Pharmaceuticals (Basel, Switzerland)
PublicationTitleAlternate Pharmaceuticals (Basel)
PublicationYear 2024
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Ohrem (ref_22) 2014; 19
Szakonyi (ref_39) 2012; 2
Snider (ref_42) 2007; 31
Delwiche (ref_16) 1991; 43
ref_13
Katsuno (ref_27) 2013; 241
Pearnchob (ref_15) 2003; 29
Hiew (ref_44) 2017; 34
Carstensen (ref_49) 1988; 77
Umprayn (ref_9) 1987; 13
Patel (ref_37) 1988; 14
Leeson (ref_35) 1958; 47
Sing (ref_30) 1985; 57
Crouter (ref_32) 2014; 15
ref_25
ref_23
Edwards (ref_50) 1952; 48
Tajarobi (ref_4) 2009; 26
Waterman (ref_12) 2002; 7
Wisselink (ref_24) 2002; 12
Maderuelo (ref_1) 2011; 154
Schaller (ref_5) 2019; 566
Moussa (ref_8) 2019; 52
Carstensen (ref_53) 1985; 74
Waterman (ref_11) 2005; 293
Waterman (ref_14) 2010; 99
Mwesigwa (ref_51) 2016; 497
Bell (ref_46) 1991; 56
Sun (ref_2) 2019; 342
Holman (ref_6) 2017; 519
Allenspach (ref_7) 2020; 583
Tarlier (ref_40) 2018; 547
Siegel (ref_52) 1962; 51
Li (ref_19) 2016; 102
Costantino (ref_31) 1998; 166
Ahlneck (ref_18) 1990; 62
Newman (ref_36) 2008; 97
Ougi (ref_45) 2020; 154
Zhang (ref_33) 2001; 90
Veronica (ref_34) 2024; 21
Zilker (ref_10) 2019; 166
Higuchi (ref_28) 2014; 123
Heidemann (ref_47) 1991; 8
Ouyang (ref_54) 2022; 27
Veronica (ref_17) 2020; 17
ref_43
ref_41
Lakio (ref_26) 2016; 511
Kestur (ref_48) 2021; 26
Parmar (ref_21) 2021; 18
Kang (ref_29) 2024; 660
Zhou (ref_20) 2016; 18
Veronica (ref_55) 2020; 580
(ref_3) 2017; 43
Jeromenok (ref_38) 2013; 29
References_xml – volume: 43
  start-page: 329
  year: 2017
  ident: ref_3
  article-title: The performance of HPMC matrix tablets using various agglomeration manufacturing processes
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.1080/03639045.2016.1249374
– volume: 57
  start-page: 603
  year: 1985
  ident: ref_30
  article-title: Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984)
  publication-title: Pure Appl. Chem.
  doi: 10.1351/pac198557040603
– volume: 166
  start-page: 211
  year: 1998
  ident: ref_31
  article-title: Water sorption behavior of lyophilized protein–sugar systems and implications for solid-state interactions
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(98)00050-7
– volume: 97
  start-page: 1047
  year: 2008
  ident: ref_36
  article-title: Characterization of the “hygroscopic” properties of active pharmaceutical ingredients
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.21033
– volume: 18
  start-page: 1213
  year: 2016
  ident: ref_20
  article-title: How much surface coating of hydrophobic azithromycin is sufficient to prevent moisture-induced decrease in aerosolisation of hygroscopic amorphous colistin powder?
  publication-title: AAPS J.
  doi: 10.1208/s12248-016-9934-x
– volume: 56
  start-page: 17
  year: 1991
  ident: ref_46
  article-title: Aspartame degradation kinetics as affected by pH in intermediate and low moisture food systems
  publication-title: J. Food Sci.
  doi: 10.1111/j.1365-2621.1991.tb07964.x
– volume: 342
  start-page: 856
  year: 2019
  ident: ref_2
  article-title: A platform direct compression formulation for low dose sustained-release tablets enabled by a dual particle engineering approach
  publication-title: Powder Technol.
  doi: 10.1016/j.powtec.2018.10.054
– volume: 27
  start-page: 1069
  year: 2022
  ident: ref_54
  article-title: Effect of drug load and lipid–wax blends on drug release and stability from spray-congealed microparticles
  publication-title: Pharm. Dev. Technol.
  doi: 10.1080/10837450.2022.2152048
– volume: 51
  start-page: 1068
  year: 1962
  ident: ref_52
  article-title: Tablets of pyrilamine resin adsorbate with aspirin and vitamin C
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600511112
– volume: 99
  start-page: 4437
  year: 2010
  ident: ref_14
  article-title: Package selection for moisture protection for solid, oral drug products
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.22161
– volume: 48
  start-page: 696
  year: 1952
  ident: ref_50
  article-title: The hydrolysis of aspirin. Part 2
  publication-title: Trans. Faraday Soc.
  doi: 10.1039/tf9524800696
– ident: ref_23
– volume: 13
  start-page: 653
  year: 1987
  ident: ref_9
  article-title: Hygroscopicity and moisture adsorption kinetics of pharmaceutical solids: A review
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.3109/03639048709105213
– volume: 2
  start-page: 18
  year: 2012
  ident: ref_39
  article-title: The effect of water on the solid state characteristics of pharmaceutical excipients: Molecular mechanisms, measurement techniques, and quality aspects of final dosage form
  publication-title: Int. J. Pharm. Investig.
  doi: 10.4103/2230-973X.96922
– ident: ref_41
  doi: 10.1007/978-3-319-20206-8_1
– volume: 31
  start-page: 56
  year: 2007
  ident: ref_42
  article-title: Implementation of water-activity testing to replace Karl Fischer water testing
  publication-title: Pharm. Technol.
– volume: 62
  start-page: 87
  year: 1990
  ident: ref_18
  article-title: The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(90)90221-O
– volume: 26
  start-page: 1496
  year: 2009
  ident: ref_4
  article-title: The impact of dose and solubility of additives on the release from HPMC matrix tablets—Identifying critical conditions
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-009-9861-y
– volume: 8
  start-page: 292
  year: 1991
  ident: ref_47
  article-title: Preformulation studies involving moisture uptake in solid dosage forms
  publication-title: Pharm. Res.
  doi: 10.1023/A:1015877011807
– volume: 14
  start-page: 77
  year: 1988
  ident: ref_37
  article-title: The effect of selected direct compression excipients on the stability of aspirin as a model hydrolyzable drug
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.3109/03639048809151962
– volume: 34
  start-page: 2675
  year: 2017
  ident: ref_44
  article-title: A study of moisture sorption and dielectric processes of starch and sodium starch glycolate
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-017-2252-x
– ident: ref_13
– volume: 12
  start-page: 151
  year: 2002
  ident: ref_24
  article-title: Mannitol production by lactic acid bacteria: A review
  publication-title: Int. Dairy J.
  doi: 10.1016/S0958-6946(01)00153-4
– volume: 241
  start-page: 60
  year: 2013
  ident: ref_27
  article-title: Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compactibility and tablet stability
  publication-title: Powder Technol.
  doi: 10.1016/j.powtec.2013.03.008
– volume: 102
  start-page: 132
  year: 2016
  ident: ref_19
  article-title: l-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2016.02.010
– volume: 29
  start-page: 925
  year: 2003
  ident: ref_15
  article-title: Pharmaceutical applications of shellac: Moisture-protective and taste-masking coatings and extended-release matrix tablets
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.1081/DDC-120024188
– volume: 18
  start-page: 907
  year: 2021
  ident: ref_21
  article-title: Co-processing of small molecule excipients with polymers to improve functionality
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1080/17425247.2021.1873946
– volume: 154
  start-page: 105502
  year: 2020
  ident: ref_45
  article-title: Effect of the molecular mobility of water adsorbed by disintegrants on storage-induced hydrolytic degradation of acetylsalicylic acid incorporated into tablets under humid conditions
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2020.105502
– volume: 566
  start-page: 615
  year: 2019
  ident: ref_5
  article-title: Systematic development of a high dosage formulation to enable direct compression of a poorly flowing API: A case study
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2019.05.073
– volume: 7
  start-page: 113
  year: 2002
  ident: ref_12
  article-title: Hydrolysis in pharmaceutical formulations
  publication-title: Pharm. Dev. Technol.
  doi: 10.1081/PDT-120003494
– volume: 26
  start-page: 41
  year: 2021
  ident: ref_48
  article-title: Effect of coating excipients on chemical stability of active coated tablets
  publication-title: Pharm. Dev. Technol.
  doi: 10.1080/10837450.2020.1832520
– volume: 583
  start-page: 119343
  year: 2020
  ident: ref_7
  article-title: Characterization of a novel hydroxypropyl methylcellulose (HPMC) direct compression grade excipient for pharmaceutical tablets
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2020.119343
– ident: ref_25
  doi: 10.1002/9781118373941
– volume: 90
  start-page: 1375
  year: 2001
  ident: ref_33
  article-title: Water vapor absorption into amorphous sucrose-poly(vinyl pyrrolidone) and trehalose–poly (vinyl pyrrolidone) mixtures
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.1090
– volume: 17
  start-page: 4616
  year: 2020
  ident: ref_17
  article-title: Insights into the moisture scavenging properties of different types of starch in tablets containing a moisture-sensitive drug
  publication-title: Mol. Pharm.
  doi: 10.1021/acs.molpharmaceut.0c00804
– volume: 15
  start-page: 65
  year: 2014
  ident: ref_32
  article-title: The effect of moisture on the flowability of pharmaceutical excipients
  publication-title: AAPS PharmSciTech
  doi: 10.1208/s12249-013-0036-0
– volume: 52
  start-page: 607
  year: 2019
  ident: ref_8
  article-title: Controlled release tablets based on HPMC:lactose blends
  publication-title: J. Drug Deliv. Sci. Technol.
  doi: 10.1016/j.jddst.2019.05.028
– volume: 660
  start-page: 124298
  year: 2024
  ident: ref_29
  article-title: Mannitol-coated hydroxypropyl methylcellulose as an alternative directly compressible controlled release excipient
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2024.124298
– volume: 166
  start-page: 222
  year: 2019
  ident: ref_10
  article-title: A systematic review of the stability of finished pharmaceutical products and drug substances beyond their labeled expiry dates
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2019.01.016
– volume: 511
  start-page: 659
  year: 2016
  ident: ref_26
  article-title: Achieving a robust drug release from extended release tablets using an integrated continuous mixing and direct compression line
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2016.07.052
– volume: 29
  start-page: 12982
  year: 2013
  ident: ref_38
  article-title: Restricted access: On the nature of adsorption/desorption hysteresis in amorphous, microporous polymeric materials
  publication-title: Langmuir
  doi: 10.1021/la402630s
– volume: 497
  start-page: 70
  year: 2016
  ident: ref_51
  article-title: An investigation into moisture barrier film coating efficacy and its relevance to drug stability in solid dosage forms
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2015.10.068
– volume: 547
  start-page: 142
  year: 2018
  ident: ref_40
  article-title: Deformation behavior of crystallized mannitol during compression using a rotary tablet press simulator
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2018.05.026
– volume: 580
  start-page: 119218
  year: 2020
  ident: ref_55
  article-title: Insights on the role of excipients and tablet matrix porosity on aspirin stability
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2020.119218
– volume: 19
  start-page: 257
  year: 2014
  ident: ref_22
  article-title: Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms?
  publication-title: Pharm. Dev. Technol.
  doi: 10.3109/10837450.2013.775154
– volume: 123
  start-page: 557
  year: 2014
  ident: ref_28
  article-title: Hygroscopicity of a sugarless coating layer formed by the interaction between mannitol and poly (vinyl alcohol)(PVA)
  publication-title: Colloids Surf. B Biointerfaces
  doi: 10.1016/j.colsurfb.2014.09.058
– volume: 43
  start-page: 85
  year: 1991
  ident: ref_16
  article-title: Examination of starch-water and cellulose-water interactions with near infrared (NIR) diffuse reflectance spectrospocy
  publication-title: Starch-Starke
  doi: 10.1002/star.19910430304
– volume: 519
  start-page: 390
  year: 2017
  ident: ref_6
  article-title: Continuous direct compression as manufacturing platform for sustained release tablets
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2017.01.010
– volume: 293
  start-page: 101
  year: 2005
  ident: ref_11
  article-title: Accelerated aging: Prediction of chemical stability of pharmaceuticals
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2004.12.013
– ident: ref_43
– volume: 47
  start-page: 329
  year: 1958
  ident: ref_35
  article-title: Decomposition of aspirin in the solid state
  publication-title: J. Am. Pharm. Assoc.
  doi: 10.1002/jps.3030470509
– volume: 74
  start-page: 741
  year: 1985
  ident: ref_53
  article-title: Decomposition of aspirin in the solid state in the presence of limited amounts of moisture
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600740709
– volume: 154
  start-page: 2
  year: 2011
  ident: ref_1
  article-title: Critical factors in the release of drugs from sustained release hydrophilic matrices
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2011.04.002
– volume: 21
  start-page: 2484
  year: 2024
  ident: ref_34
  article-title: Understanding the roles of excipients in moisture management in solid dosage forms
  publication-title: Mol. Pharm.
  doi: 10.1021/acs.molpharmaceut.4c00031
– volume: 77
  start-page: 318
  year: 1988
  ident: ref_49
  article-title: Decomposition of aspirin in the solid state in the presence of limited amounts of moisture III: Effect of temperature and a possible mechanism
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600770407
SSID ssj0057141
Score 2.3595593
Snippet Background/Objectives: Hydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for...
Hydroxypropyl methylcellulose (HPMC) is one of the most commonly used hydrophilic polymers in formulations of matrix tablets for controlled release...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1167
SubjectTerms Aspirin
co-processed
Competition
Controlled release technology
Drug dosages
Excipients
Humidity
hydroxypropyl methylcellulose
Mannitol
Methylcellulose
Moisture
Moisture absorption
Moisture content
Particle size
Pharmaceutical research
Pharmaceuticals
Porous materials
stability
Water
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yT76I31ZPiSgnwpVrk34kvq3rHYuwsugd3FtJ0vTuoLTLdgv2b_Gfdabpbrco-OI-NtNu0pnM_KbM_ELI-8KmsRXY9iF14kcyUb7Mc-brKIdkguko0dicvPyWLK6ir9fx9cFRX1gT5uiB3Ys7U6IIpEl5XhQacgEjreVGF0YwbaViPRMoxLxdMuV8cJyGUejISDkk9Wfr2zAFobA_TX4MPz1L_5---CAYTQslDyLPxUPyYICMdOam-ojcs9VjcrJynNPdKb0cW6iaU3pCVyMbdfeE_MJjkGHblv68BlyZ00WXY-kKTGPdlXRpQVMlfr5vy7qxVDVUUecHy46it-gLZXVp6dxVtZfwjO8QrCD80fOf5m6NHZUUsC9d1mAz7cb6P7AqHv0o_bJpb5pPdEYB1PZluB1dje2dT8nVxfnlfOEPJzL4BpDd1s-V4WmslTBKA1KIuUoizYuAi0hqnQKcY4DYo4AzzdJcJiYEzcW2EIHQSoUBf0aOqrqyLwiVhTbMMIvqjZLQgp41aDcJleAGNOWRjztFZWagK8dTM8oM0hZUajYq1SPv9rJrR9LxV6nPqO-9BBJr9xfA3LLB3LJ_mZtHPqC1ZLj9YTpGDV0MsCgk0spmAvJp_DGPHE8kYdua6fDO3rLBbTQZBzCWxFJG8D9v98N4J5bCVbZunQxgPJEKjzx35rlfEpf4xYEHHhETw52seTpS3d32pOIhAmeehi__x1t6Re4zAH-uFu-YHG03rX0N4G2r3_T79DeQYUlJ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGeOEF8U1gICPQENICie3ENhJCpWyqkIoqWKW9RbbjbJOipvRDWv4W_lnukrRdYKKP9aU95-58v0vug5A3hZeJV1j2oW0aCp2aUOc5C63IIZhgVqQWi5PH39PRVHw7S872yGZ-Z3cDlzeGdjhParoo31_9qj-DwX_CiBNC9g_zi1iC24tTeYvcBo8k0UDHYvs2IZGxiNvWpH_R95xR07P_35P5mmvqp01e80Mn98jdDkDSQSvx-2TPzx6Qw0nbgbo-oqe7gqrlET2kk11v6voh-Y1DkcGIy3BYAcrM6ajOMZEF2JjXJR17kFuJD_PXZbX01Cypoe2pWNYUz44mbdaWng7bHPcSfuMHuC5whvT4yl3Osb6SAhKm4wo0aL3w4U_MkcdTlX5drM-XH-mAAsRtknJrOtkVez4i05Pj0-Eo7OYzhA5w3irMjeMysUY5YwE3JNykwvIi4kpoayWAOwb4XUScWSZznbrYSZ74QkXKGhNH_DHZn1Uz_5RQXVjHHPOqAA1JY29UYWOn09go7kBSAXm3EVTmuublOEOjzCCIQaFmO6EG5PWWdt627LiR6gvKe0uBbbabL6rFedZZbWaQH2A6LwoLgajT3nNnC6eY9dowEZC3qC0Zqiew40xX0wCbwrZa2UBBdI0fFpCDHiUYsesvb_Qt29hAxgGapYnWAv7n1XYZr8TEuJmv1i0NID4lVUCetOq53RLX-PyBRwFRPcXt7bm_Mru8aFqMxwijuYyf_Z-v5-QOA5DX5twdkP3VYu1fAEhb2ZeNBf4BQypAnw
  priority: 102
  providerName: Scholars Portal
Title Mannitol-Coated Hydroxypropyl Methylcellulose as a Directly Compressible Controlled Release Excipient for Moisture-Sensitive Drugs: A Stability Perspective
URI https://www.ncbi.nlm.nih.gov/pubmed/39338330
https://www.proquest.com/docview/3110659944
https://www.proquest.com/docview/3110910878
https://pubmed.ncbi.nlm.nih.gov/PMC11435371
https://doaj.org/article/a8f09c73dffb401c9ee3cbfc82be9a24
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdb-7KXse9564rGRsegprYk29JeRpqlhEFK6From5FkuS2YOIsTmP-W_bO7s524ZmN5yEMkmxN3uvvd5T4I-Zi7JHISyz6UiX2hYu2rLGO-ERk4E8yI2GBx8uw8nl6J79fRdRdwq7q0yq1ObBR1VlqMkZ9wsFNxpJQQX5c_fZwahf-udiM0HpJ9UMESnK_908n5_GKri6MkFGHblJSDc3-yvA0TMJBhM1W-N0NNt_6_dfI9ozRMmLxngc6ekMcddKSjltdPyQO3eEaO5m3v6fqYXvalVNUxPaLzvit1_Zz8xnHIcH0Lf1wCvszotM4whQXIWNYFnTngWIFh_E1RVo7qimra6sOipqg1moRZUzg6brPbC3jHBRgtMIN08sveLbGykgIGprMSZGezcv4PzI5HfUq_rTY31Rc6ogBum3Tcms77Ms8X5Opscjme-t1kBt8Cwlv7mbY8iYyWVhtADBHXsTA8D7gUypgEYB0D5C4CzgxLMhXb0CY8crkMpNE6DPhLsrcoF-41oSo3llnmZA6yEYdOy9yEVsWhltwCpzzyecuo1HZty3F6RpGC-4JMTXumeuTDbu-ybdbxz12nyO_dDmyw3fxQrm7S7r6mGukBorM8N-CCWuUctya3khmnNBMe-YTSkqIaAHKs7qoZ4FDYUCsdSfCr8cM8cjDYCdfXDpe38pZ26qNKe2H3yPvdMj6JKXELV27aPYD1ZCI98qoVz92RuMLIAw88IgeCOzjzcGVxd9s0Fw8RQPMkfPN_ut6SRwzgXZttd0D21quNewfwbG0Ouzt42IQ34Hsm5B-Rq0IB
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2V9AFeEHcMBRYBRUi1au_6souEUJq2SmkTRSWV-mZ21-u2khWHXAT-Fv6Bb2TGdpJGIN6ax-zY2tWMz5yx50LI28zGoRVY9iF15AYyUq5MU-bqIIVggukg0lic3OtH3bPgy3l4vkF-L2phMK1ygYkVUKeFwXfkuxz8VBRKGQSfx99dnBqFX1cXIzRqszi25Q8I2aafjvZBv-8YOzwYdrpuM1XANcBOZm6qDI9DrYRRGrxdyFUUaJ55XARS6xgoCQPWGXicaRanMjK-iXloM-EJrZTvcbjvLbIZcAhlWmRz76A_OF1gfxj7gV83QeVcervjSz8Gh-xXU-xXbq-aDvC3D7jmBNcTNK95vMN75G5DVWm7tq37ZMOOHpDtQd3rutyhw1Xp1nSHbtPBqgt2-ZD8wvHLABe52ymAz6a0W6aYMgPbGJc57VmwkBw_G8zzYmqpmlJFa_zNS4ooVSXo6tzSTp1Nn8M9TsFJgtulBz_N1RgrOSlwbtorwFbnE-t-xWx8xG-6P5lfTD_SNgUyXaX_lnSwKit9RM5uRGePSWtUjOxTQmWmDTPMigxsMfKtEpn2jYx8JbgBTTnkw0JRiWnapOO0jjyBcAmVmqyU6pA3S9lx3Rzkn1J7qO-lBDb0rv4oJhdJgw-Jwv3AptMs0xDyGmktNzozgmkrFQsc8h6tJUHYge0Y1VRPwKGwgVfSFhDH4485ZGtNEuDCrC8v7C1p4GqarB4uh7xeLuOVmII3ssW8lgFuKWLhkCe1eS6PxCW-6eCeQ8Sa4a6deX1ldHVZNTP3kbDz2H_2_329Ire7w95JcnLUP35O7jCglnWm3xZpzSZz-wKo4Uy_bJ5HSr7dNAT8AYfve98
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELVKKyFeEPcGChgBRUiNmti52EgI9bZqKV2tSiv1LdiO01aKNsumK8i38Cd8HTO5bLoC8dY8xk5ka8ZnziRzIeRNZuPQCkz7kDpyAxkpV6Ypc3WQgjPBdBBpTE4-Gkb7p8Hns_BsifzucmEwrLLDxBqo08LgN_JNDnYqCqUMgs2sDYsY7Q4-Tb672EEK_7R27TQaFTm01Q9w38qPB7sg67eMDfZOdvbdtsOAa4CpXLmpMjwOtRJGabB8IVdRoHnmcRFIrWOgJwwYaOBxplmcysj4JuahzYQntFK-x-G9t8hKDF6Rt0xWtveGo-PODoSxH_hNQVTOpbc5ufBjMM5-3dG-N4F1p4C_7cE1g7gYrHnN-g3ukbstbaVbjZ7dJ0t2_ICsj5q619UGPenTuMoNuk5HfUXs6iH5ha2YATpyd6cAbpvS_SrF8BlYxqTK6ZEFbcnxF8IsL0pLVUkVbbA4rygiVh2sq3NLd5rI-hzecQwGE0ww3ftpLieY1UmBf9OjAvR2NrXuV4zMRyynu9PZefmBblEg1nUocEVHfYrpI3J6IzJ7TJbHxdiuEiozbZhhVmSgl5Fvlci0b2TkK8ENSMoh7ztBJaYtmY6dO_IEXCcUatIL1SGv53MnTaGQf87aRnnPZ2Bx7_pGMT1PWqxIFK4HFp1mmQb310hrudGZEUxbqVjgkHeoLQlCECzHqDaTAjaFxbySLQE-PV7MIWsLMwE6zOJwp29JC11l0h80h7yaD-OTGI43tsWsmQM8U8TCIU8a9ZxviUv86sE9h4gFxV3Y8-LI-PKiLmzuI3nnsf_0_-t6SW7D0U--HAwPn5E7DFhmE_S3RpavpjP7HFjilX7RHkdKvt00AvwBDVmAFA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mannitol-Coated+Hydroxypropyl+Methylcellulose+as+a+Directly+Compressible+Controlled+Release+Excipient+for+Moisture-Sensitive+Drugs%3A+A+Stability+Perspective&rft.jtitle=Pharmaceuticals+%28Basel%2C+Switzerland%29&rft.au=Christina+Yong+Xin+Kang&rft.au=Chow%2C+Keat+Theng&rft.au=Lui%2C+Yuan+Siang&rft.au=Antoine+Salome&rft.date=2024-09-01&rft.pub=MDPI+AG&rft.eissn=1424-8247&rft.volume=17&rft.issue=9&rft.spage=1167&rft_id=info:doi/10.3390%2Fph17091167&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-8247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-8247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-8247&client=summon